Skip to main content
Top
Published in: Diabetologia 10/2005

01-10-2005 | Review

Canine diabetes mellitus: can old dogs teach us new tricks?

Authors: B. Catchpole, J. M. Ristic, L. M. Fleeman, L. J. Davison

Published in: Diabetologia | Issue 10/2005

Login to get access

Abstract

Background

Diabetes is common in dogs, with an estimated prevalence of 0.32% in the UK. Clinical signs, as in man, include polydipsia, polyuria and weight loss, associated with hyperglycaemia and glucosuria. Diabetes typically occurs in dogs between 5 and 12 years of age, and is uncommon under 3 years of age. Breeds predisposed to diabetes include the Samoyed, Tibetan Terrier and Cairn Terrier, while others such as the Boxer and German Shepherd Dog seem less susceptible. These breed differences suggest a genetic component, and at least one dog leucocyte antigen haplotype (DLA DRB1*009, DQA1*001, DQB1*008) appears to be associated with susceptibility to diabetes.

Methods

Canine diabetes can be classified into insulin deficiency diabetes (IDD), resulting from a congenital deficiency or acquired loss of pancreatic beta cells, or insulin resistance diabetes resulting mainly from hormonal antagonism of insulin function.

Results

There is no evidence for a canine equivalent of human type 2 diabetes. Adult-onset IDD, requiring insulin therapy, is the most common form, with pancreatitis and/or immune-mediated beta cell destruction considered to be the major underlying causes of the disease.

Discussion

Autoantibodies to insulin, recombinant canine GAD65 and/or canine islet antigen-2 have been identified in a proportion of newly diagnosed diabetic dogs, suggesting that autoimmunity is involved in the pathogenesis of disease in some patients.

Conclusion

The late onset and slow progression of beta cell dysfunction in canine diabetes resembles latent autoimmune diabetes of the adult in man.
Literature
1.
go back to reference Von Mering J, Minkowski O (1890) Diabetes mellitus nach pancreas extirpation. Arch Exp Pathol Pharmakol 26:371–381CrossRef Von Mering J, Minkowski O (1890) Diabetes mellitus nach pancreas extirpation. Arch Exp Pathol Pharmakol 26:371–381CrossRef
2.
go back to reference Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA (1922) Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J 12:141–146 Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA (1922) Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J 12:141–146
3.
go back to reference Kim SC, We YM, Lee JH, Kang HY, Han DJ (1988) Impact of purification of pancreatic islets in canine intraportal islet transplantation. Transplant Proc 30:3423–3424CrossRef Kim SC, We YM, Lee JH, Kang HY, Han DJ (1988) Impact of purification of pancreatic islets in canine intraportal islet transplantation. Transplant Proc 30:3423–3424CrossRef
4.
go back to reference Wilkinson JS (1960) Spontaneous diabetes mellitus. Vet Rec 72:548–553 Wilkinson JS (1960) Spontaneous diabetes mellitus. Vet Rec 72:548–553
5.
go back to reference Mattheeuws D, Rottiers R, Kaneko JJ, Vermeulen A (1984) Diabetes mellitus in dogs: relationship of obesity to glucose tolerance and insulin response. Am J Vet Res 45:98–103PubMed Mattheeuws D, Rottiers R, Kaneko JJ, Vermeulen A (1984) Diabetes mellitus in dogs: relationship of obesity to glucose tolerance and insulin response. Am J Vet Res 45:98–103PubMed
6.
go back to reference Guptill L, Glickman L, Glickman N (2003) Time trends and risk factors for diabetes mellitus in dogs: analysis of veterinary medical database records (1970–1999). Vet J 165:240–247CrossRefPubMed Guptill L, Glickman L, Glickman N (2003) Time trends and risk factors for diabetes mellitus in dogs: analysis of veterinary medical database records (1970–1999). Vet J 165:240–247CrossRefPubMed
7.
go back to reference Marmor M, Willeberg P, Glickman LT, Priester WA, Cypess RH, Hurvitz AI (1982) Epizootiologic patterns of diabetes mellitus in dogs. Am J Vet Res 43:465–470PubMed Marmor M, Willeberg P, Glickman LT, Priester WA, Cypess RH, Hurvitz AI (1982) Epizootiologic patterns of diabetes mellitus in dogs. Am J Vet Res 43:465–470PubMed
8.
go back to reference Davison LJ, Herrtage ME, Catchpole B (2004) Canine diabetes mellitus in the UK: a study of 253 dogs with naturally occurring disease. Vet Rec 156:467–471 Davison LJ, Herrtage ME, Catchpole B (2004) Canine diabetes mellitus in the UK: a study of 253 dogs with naturally occurring disease. Vet Rec 156:467–471
9.
go back to reference Kennedy LJ, Davison LJ, Barnes A, Isherwood D, Ollier WER, Catchpole B (2003) Susceptibility to canine diabetes mellitus is associated with MHC class II polymorphisms. British Small Animal Veterinary Association Congress 2003, Sci Proc 593 (Abstract) Kennedy LJ, Davison LJ, Barnes A, Isherwood D, Ollier WER, Catchpole B (2003) Susceptibility to canine diabetes mellitus is associated with MHC class II polymorphisms. British Small Animal Veterinary Association Congress 2003, Sci Proc 593 (Abstract)
10.
go back to reference Foster SJ (1975) Diabetes mellitus—a study of the disease in the dog and cat in Kent. J Small Anim Pract 16:295–315PubMed Foster SJ (1975) Diabetes mellitus—a study of the disease in the dog and cat in Kent. J Small Anim Pract 16:295–315PubMed
11.
go back to reference Atkins CE, Macdonald MJ (1987) Canine diabetes mellitus has a seasonal incidence: implications relevant to human diabetes. Diabetes Res 5:83–87PubMed Atkins CE, Macdonald MJ (1987) Canine diabetes mellitus has a seasonal incidence: implications relevant to human diabetes. Diabetes Res 5:83–87PubMed
12.
13.
go back to reference Hess RS, Ward CR (2000) Effect of insulin dosage on glycaemic response in dogs with diabetes mellitus: 221 cases (1993–1998). J Am Vet Med Assoc 216:217–221PubMed Hess RS, Ward CR (2000) Effect of insulin dosage on glycaemic response in dogs with diabetes mellitus: 221 cases (1993–1998). J Am Vet Med Assoc 216:217–221PubMed
14.
go back to reference Davison LJ, Podd SL, Ristic JM, Herrtage ME, Parnham A, Catchpole B (2002) Evaluation of two point-of-care analysers for measurement of fructosamine or haemoglobin A1c in dogs. J Small Anim Pract 43:526–532PubMed Davison LJ, Podd SL, Ristic JM, Herrtage ME, Parnham A, Catchpole B (2002) Evaluation of two point-of-care analysers for measurement of fructosamine or haemoglobin A1c in dogs. J Small Anim Pract 43:526–532PubMed
15.
go back to reference Hess RS, Kass PH, Van Winkle TJ (2003) Association between diabetes mellitus, hypothyroidism or hyperadrenocorticism and atherosclerosis in dogs. J Vet Intern Med 17:489–494CrossRefPubMed Hess RS, Kass PH, Van Winkle TJ (2003) Association between diabetes mellitus, hypothyroidism or hyperadrenocorticism and atherosclerosis in dogs. J Vet Intern Med 17:489–494CrossRefPubMed
16.
go back to reference Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633PubMed Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633PubMed
17.
go back to reference Gepts W, Toussaint D (1967) Spontaneous diabetes in dogs and cats. A pathological study. Diabetologia 3:249–265CrossRefPubMed Gepts W, Toussaint D (1967) Spontaneous diabetes in dogs and cats. A pathological study. Diabetologia 3:249–265CrossRefPubMed
18.
go back to reference Alejandro R, Feldman EC, Shienvold FL, Mintz DH (1988) Advances in canine diabetes mellitus research: etiopathology and results of islet transplantation. J Am Vet Med Assoc 193:1050–1055PubMed Alejandro R, Feldman EC, Shienvold FL, Mintz DH (1988) Advances in canine diabetes mellitus research: etiopathology and results of islet transplantation. J Am Vet Med Assoc 193:1050–1055PubMed
19.
go back to reference Atkins CE, Hill JR, Johnson RK (1979) Diabetes mellitus in the juvenile dog: a report of four cases. J Am Vet Med Assoc 175:362–368PubMed Atkins CE, Hill JR, Johnson RK (1979) Diabetes mellitus in the juvenile dog: a report of four cases. J Am Vet Med Assoc 175:362–368PubMed
20.
go back to reference Atkins CE, LeCompte PM, Chin HP, Hill JR, Ownby CL, Brownfield MS (1988) Morphological and immunocytochemical study of young dogs with diabetes mellitus associated with pancreatic islet hypoplasia. Am J Vet Res 49:1577–1581PubMed Atkins CE, LeCompte PM, Chin HP, Hill JR, Ownby CL, Brownfield MS (1988) Morphological and immunocytochemical study of young dogs with diabetes mellitus associated with pancreatic islet hypoplasia. Am J Vet Res 49:1577–1581PubMed
21.
go back to reference Imamura T, Koffler M, Helderman JH et al (1988) Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycaemia. Diabetes 37:600–609PubMed Imamura T, Koffler M, Helderman JH et al (1988) Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycaemia. Diabetes 37:600–609PubMed
22.
go back to reference Kramer JW (1981) Animal model of human disease: inherited early-onset, insulin-requiring diabetes mellitus in Keeshond dogs. Am J Pathol 105:194–196PubMed Kramer JW (1981) Animal model of human disease: inherited early-onset, insulin-requiring diabetes mellitus in Keeshond dogs. Am J Pathol 105:194–196PubMed
23.
go back to reference Kramer JW, Klaasen JK, Baskin DG et al (1988) Inheritance of diabetes mellitus in Keeshond dogs. Am J Vet Res 49:428–431PubMed Kramer JW, Klaasen JK, Baskin DG et al (1988) Inheritance of diabetes mellitus in Keeshond dogs. Am J Vet Res 49:428–431PubMed
24.
go back to reference Williams DA (2000) Exocrine pancreatic disease. In: Ettinger SJ, Feldman EC (eds) Textbook of veterinary internal medicine. 5th edn. WB Saunders, Philadelphia, pp 1345–1367 Williams DA (2000) Exocrine pancreatic disease. In: Ettinger SJ, Feldman EC (eds) Textbook of veterinary internal medicine. 5th edn. WB Saunders, Philadelphia, pp 1345–1367
25.
go back to reference Watson PJ (2003) Exocrine pancreatic insufficiency as an end stage of pancreatitis in four dogs. J Small Anim Pract 44:306–312PubMed Watson PJ (2003) Exocrine pancreatic insufficiency as an end stage of pancreatitis in four dogs. J Small Anim Pract 44:306–312PubMed
26.
go back to reference Rabinovitch A (1998) An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14:129–159CrossRefPubMed Rabinovitch A (1998) An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14:129–159CrossRefPubMed
27.
go back to reference Hoenig M (2002) Comparative aspects of diabetes mellitus in dogs and cats. Mol Cell Endocrinol 197:221–229CrossRefPubMed Hoenig M (2002) Comparative aspects of diabetes mellitus in dogs and cats. Mol Cell Endocrinol 197:221–229CrossRefPubMed
28.
go back to reference Hess RS, Saunders HM, Van Winkle TJ, Ward CR (2000) Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993–1998). J Am Vet Med Assoc 217:1166–1173PubMed Hess RS, Saunders HM, Van Winkle TJ, Ward CR (2000) Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993–1998). J Am Vet Med Assoc 217:1166–1173PubMed
29.
go back to reference Westermarck E, Willberg M (2003) Exocrine pancreatic insufficiency in dogs. Vet Clin North Am Small Anim Pract 33:1165–1179CrossRefPubMed Westermarck E, Willberg M (2003) Exocrine pancreatic insufficiency in dogs. Vet Clin North Am Small Anim Pract 33:1165–1179CrossRefPubMed
30.
go back to reference Hall EJ, Bond PM, McLean C, Batt RM, McLean L (1991) A survey of the diagnosis and treatment of canine exocrine pancreatic insufficiency. J Small Anim Pract 32:613–619 Hall EJ, Bond PM, McLean C, Batt RM, McLean L (1991) A survey of the diagnosis and treatment of canine exocrine pancreatic insufficiency. J Small Anim Pract 32:613–619
31.
go back to reference Whitney MS, Boon GD, Rebar AH, Story JA, Bottoms GD (1993) Ultracentrifugal and electrophoretic characteristics of the plasma lipoproteins of Miniature Schnauzer dogs with idiopathic hyperlipoproteinemia. J Vet Intern Med 7:253–260PubMed Whitney MS, Boon GD, Rebar AH, Story JA, Bottoms GD (1993) Ultracentrifugal and electrophoretic characteristics of the plasma lipoproteins of Miniature Schnauzer dogs with idiopathic hyperlipoproteinemia. J Vet Intern Med 7:253–260PubMed
32.
go back to reference Mansfield CS, Jones BR, Spillman T (2003) Assessing the severity of canine pancreatitis. Res Vet Sci 74:137–144CrossRefPubMed Mansfield CS, Jones BR, Spillman T (2003) Assessing the severity of canine pancreatitis. Res Vet Sci 74:137–144CrossRefPubMed
33.
34.
go back to reference Simpson JW, Doxey DL (1990) Serum amylase and isoamylase values in dogs with pancreatic disease. Vet Res Commun 14:453–459CrossRefPubMed Simpson JW, Doxey DL (1990) Serum amylase and isoamylase values in dogs with pancreatic disease. Vet Res Commun 14:453–459CrossRefPubMed
35.
go back to reference Williams DA, Batt RM (1988) Sensitivity and specificity of radioimmunoassay of serum trypsin-like immunoreactivity for the diagnosis of canine exocrine pancreatic insufficiency. J Am Vet Med Assoc 192:195–201PubMed Williams DA, Batt RM (1988) Sensitivity and specificity of radioimmunoassay of serum trypsin-like immunoreactivity for the diagnosis of canine exocrine pancreatic insufficiency. J Am Vet Med Assoc 192:195–201PubMed
36.
go back to reference Steiner JM, Williams DA (2003) Development and validation of a radioimmunoassay for the measurement of canine pancreatic lipase immunoreactivity in serum of dogs. Am J Vet Res 64:1237–1241PubMed Steiner JM, Williams DA (2003) Development and validation of a radioimmunoassay for the measurement of canine pancreatic lipase immunoreactivity in serum of dogs. Am J Vet Res 64:1237–1241PubMed
37.
go back to reference Davison LJ, Herrtage ME, Steiner JM, Williams DA, Catchpole B (2003) Evidence of anti-insulin autoreactivity and pancreatic inflammation in newly-diagnosed diabetic dogs. J Vet Intern Med 17:395 (Abstract) Davison LJ, Herrtage ME, Steiner JM, Williams DA, Catchpole B (2003) Evidence of anti-insulin autoreactivity and pancreatic inflammation in newly-diagnosed diabetic dogs. J Vet Intern Med 17:395 (Abstract)
38.
go back to reference Cook AK, Breitschwerdt EB, Levine JF, Bunch SE, Linn LO (1993) Risk factors associated with acute pancreatitis in dogs 101 cases (1985–1990). J Am Vet Med Assoc 203:673–679PubMed Cook AK, Breitschwerdt EB, Levine JF, Bunch SE, Linn LO (1993) Risk factors associated with acute pancreatitis in dogs 101 cases (1985–1990). J Am Vet Med Assoc 203:673–679PubMed
39.
go back to reference Sai P, Debray-Sachs M, Jondet A, Gepts W, Assan R (1984) Anti-beta cell immunity in insulinopenic diabetic dogs. Diabetes 33:135–140PubMed Sai P, Debray-Sachs M, Jondet A, Gepts W, Assan R (1984) Anti-beta cell immunity in insulinopenic diabetic dogs. Diabetes 33:135–140PubMed
40.
go back to reference Montgomery TM, Nelson RW, Feldman EC, Robertson K, Polonsky KS (1996) Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus and dogs with hyperadrenocorticism. J Vet Intern Med 10:116–122PubMed Montgomery TM, Nelson RW, Feldman EC, Robertson K, Polonsky KS (1996) Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus and dogs with hyperadrenocorticism. J Vet Intern Med 10:116–122PubMed
41.
go back to reference Rand JS, Fleeman LM, Farrow HA, Appleton DJ, Lederer R (2004) Canine and feline diabetes mellitus: nature or nurture? J Nutr 134:2072–2080 Rand JS, Fleeman LM, Farrow HA, Appleton DJ, Lederer R (2004) Canine and feline diabetes mellitus: nature or nurture? J Nutr 134:2072–2080
42.
go back to reference Zimmet PZ, Tuomi T, Mackay IR et al (1994) Latent autoimmune diabetes in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299–303PubMed Zimmet PZ, Tuomi T, Mackay IR et al (1994) Latent autoimmune diabetes in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299–303PubMed
43.
go back to reference Hoenig M, Dawe DL (1992) A qualitative assay for beta cell antibodies. Preliminary results in dogs with diabetes mellitus. Vet Immunol Immunopathol 32:195–203CrossRefPubMed Hoenig M, Dawe DL (1992) A qualitative assay for beta cell antibodies. Preliminary results in dogs with diabetes mellitus. Vet Immunol Immunopathol 32:195–203CrossRefPubMed
44.
go back to reference Haines DM, Penhale WJ (1985) Autoantibodies to pancreatic islet cells in canine diabetes mellitus. Vet Immunol Immunopathol 8:149–156CrossRefPubMed Haines DM, Penhale WJ (1985) Autoantibodies to pancreatic islet cells in canine diabetes mellitus. Vet Immunol Immunopathol 8:149–156CrossRefPubMed
45.
go back to reference Davison LJ, Weenink SM, Christie MR, Herrtage ME, Catchpole B (2003) Autoantibodies to pancreatic proteins (GAD65 and IA-2) in canine diabetes mellitus. J Vet Intern Med 17:738 (Abstract) Davison LJ, Weenink SM, Christie MR, Herrtage ME, Catchpole B (2003) Autoantibodies to pancreatic proteins (GAD65 and IA-2) in canine diabetes mellitus. J Vet Intern Med 17:738 (Abstract)
46.
go back to reference Todd JA, Bell JI, McDevitt HO (1990) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599–604CrossRef Todd JA, Bell JI, McDevitt HO (1990) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599–604CrossRef
47.
go back to reference Redondo MJ, Eisenbarth GS (2002) Genetic control of autoimmunity in Type 1 diabetes and associated disorders. Diabetologia 45:605–622CrossRefPubMed Redondo MJ, Eisenbarth GS (2002) Genetic control of autoimmunity in Type 1 diabetes and associated disorders. Diabetologia 45:605–622CrossRefPubMed
48.
go back to reference Khalil I, d’Auriol L, Gobet M et al (1990) A combination of HLA-DQ beta Asp57-negative and HLA-DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85:1315–1319PubMed Khalil I, d’Auriol L, Gobet M et al (1990) A combination of HLA-DQ beta Asp57-negative and HLA-DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85:1315–1319PubMed
49.
go back to reference Selman PJ, Mol JA, Ruttemen GR, van Garderen E, Rijnberk A (1984) Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134:287–292CrossRef Selman PJ, Mol JA, Ruttemen GR, van Garderen E, Rijnberk A (1984) Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134:287–292CrossRef
50.
go back to reference Eigenmann JE, Eigenmann RY, Rijnberk A et al (1983) Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocrinol (Copenh) 104:167–176 Eigenmann JE, Eigenmann RY, Rijnberk A et al (1983) Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocrinol (Copenh) 104:167–176
51.
go back to reference Peterson ME, Altszuler N, Nichols CE (1984) Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism. Res Vet Sci 36:177–182PubMed Peterson ME, Altszuler N, Nichols CE (1984) Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism. Res Vet Sci 36:177–182PubMed
52.
go back to reference Truett AA, Borne AT, Monteiro MP, West DB (1998) Composition of dietary fat affects blood pressure and insulin responses to dietary obesity in the dog. Obes Res 6:137–146PubMed Truett AA, Borne AT, Monteiro MP, West DB (1998) Composition of dietary fat affects blood pressure and insulin responses to dietary obesity in the dog. Obes Res 6:137–146PubMed
Metadata
Title
Canine diabetes mellitus: can old dogs teach us new tricks?
Authors
B. Catchpole
J. M. Ristic
L. M. Fleeman
L. J. Davison
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1921-1

Other articles of this Issue 10/2005

Diabetologia 10/2005 Go to the issue

Letter

Comment

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine